Two Cases of Long-Term Control of Metastatic Colorectal Cancer via FTD/TPI plus Bevacizumab in Elderly Patients

With advances in new cytotoxic drugs and molecular-targeted drugs, the prognosis of patients with metastatic colorectal cancer (mCRC) has improved. However, physicians often hesitate to administer intensive standard regimens to elderly patients with mCRC. Recently, first-line regimens that are effec...

Full description

Bibliographic Details
Main Authors: Masatsune Shibutani, Kiyoshi Maeda, Hisashi Nagahara, Tatsunari Fukuoka, Yasuhito Iseki, Shinji Matsutani, En Wang, Kosei Hirakawa, Masaichi Ohira
Format: Article
Language:English
Published: Karger Publishers 2018-11-01
Series:Case Reports in Oncology
Subjects:
Online Access:https://www.karger.com/Article/FullText/493849